Skip to content

Surgical Correction of Moderate Ischemic Mitral Regurgitation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00394797
Enrollment
Unknown
Registered
2006-11-01
Start date
Unknown
Completion date
Unknown
Last updated
2011-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate Ischemic Mitral Regurgitation

Brief summary

The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups. Primary endpoints include late survival. Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.

Interventions

Sponsors

Shaare Zedek Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* patients undergoing coronary bypass surgery who have moderate degree of ischemic MR

Exclusion criteria

* etiology of mitral regurgitation other than ischemic, degree of regurgitation other than moderate.

Design outcomes

Primary

MeasureTime frame
survival at 1,5 and 10 years

Secondary

MeasureTime frame
event free survival
symptoms
echocardiographic parameters

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026